Issue 38 - Oct. 11, 2019
Issue 37 - Oct. 4, 2019
Issue 36 - Sep. 27, 2019
  • An Appreciation

    Jerry D. Boyd, founding editor of The Cancer Letter, pioneer of cancer journalism, dies at 91

    Nearly half a century ago, Jerry Dock Boyd started covering the opening shots of the War on Cancer.

  • E-cigarette use rises in young adults as combustible cigarette use declines

    E-cigarette use is on the rise among young adults, but overall combustible cigarette use among teens is continuing on a downward trend, recent studies show.

  • Real-World Evidence

    Oncologists quickly react to label changes for immunotherapies, a study by Penn, Flatiron shows

    In an unprecedented use of real-world data, researchers at the University of Pennsylvania and Flatiron Health have determined that oncologists are responding quickly to label restrictions announced by FDA.

  • In Brief

    • Winship’s Curran receives ASTRO Gold Medal
    • Fairness to Kids with Cancer Act is introduced in the House
    • Brereton, Dornsife receive NCCS Stovall award
    • AdventHealth, Moffitt form collaboration
    • UMich and Karmanos get $9.2M prostate cancer SPORE grant
    • Six researchers receive $14M for cancer genomics research
    • Weitzel and Blazer win ASHG Arno Motulsky-Barton Childs Award
    • Jandial receives $1.35M DoD grant for LMD study
  • TCCL Logo

  • Trials & Tribulations

    Reducing re-excisions

    How intraoperative 3-D specimen tomosynthesis ensures fewer repeat breast cancer surgeries

    This year in the United States, nearly 270,000 women will receive the devastating news that they have breast cancer.  Many will choose breast-conserving surgery, commonly referred to as lumpectomy, wherein the surgeon seeks to remove the malignant tumor, while also preserving as much healthy breast tissue as possible.

  • Clinical Roundup

    • Breast cancer patients who exercise pre-diagnosis are at lower risk for heart disease
    • One in five young adults regularly uses e-cigarettes and believes they are harmless, not addictive
    • Univ. of Arizona researchers look to treat neuropathic pain caused by chemotherapy without using opioids.
  • Drugs & Targets

    • FDA approves Janssen’s Darzalex for new multiple myeloma indication
    • Cologuard gets FDA approval for use in younger patients indication
    • Astellas gets CHMP nod for Xospata as monotherapy for an AML indication
    • CHMP recommends approval for Bavencio + Axitinib for first-line treatment of advanced RCC
    • Celsius Therapeutics brings genomics platform to three institutions worldwide
    • Evotec, Takeda collaborate on drug discovery
    • Foundation Medicine, Natera to advance personalized cancer monitoring
    • Adaptive Biotechnologies, Amgen use clonoSEQ as preferred MRD test